HEPATOLOGÍA EXPERIMENTAL Y VECTORIZACIÓN DE FÁRMACOS
HEVEFARM
Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Diabetes y Enfermedades Metabolicas Asociadas (5)
2023
-
Exploring the Effects of Metabolism-Disrupting Chemicals on Pancreatic α-Cell Viability, Gene Expression and Function: A Screening Testing Approach
International Journal of Molecular Sciences, Vol. 24, Núm. 2
2022
-
Metabolic-associated fatty liver disease: From simple steatosis toward liver cirrhosis and potential complications. Proceedings of the Third Translational Hepatology Meeting, organized by the Spanish Association for the Study of the Liver (AEEH)
Gastroenterologia y Hepatologia, Vol. 45, Núm. 9, pp. 724-734
2020
-
Bisphenol-A exposure during pregnancy alters pancreatic β-cell division and mass in male mice offspring: A role for ERβ
Food and Chemical Toxicology, Vol. 145
-
C3G contributes to platelet activation and aggregation by regulating major signaling pathways
Signal Transduction and Targeted Therapy, Vol. 5, Núm. 1
-
Liver and gastrointestinal cancers
DRUG EFFLUX PUMPS IN CANCER RESISTANCE PATHWAYS: FROM MOLECULAR RECOGNITION AND CHARACTERIZATION TO POSSIBLE INHIBITION STRATEGIES IN CHEMOTHERAPY (ACADEMIC PRESS LTD-ELSEVIER SCIENCE LTD), pp. 197-250